Clinical trial Recruiting at 1 site Observational Ages 18 and up

Brazilian Portuguese version of EmPHasis-10 for pulmonary hypertension

Official title: Cultural Adaptation, Validation, and Reliability of the EMPHASIS-10 Questionnaire for Assessing Quality of Life in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Brazilian Version

Run by Hospital de Clinicas de Porto Alegre · NCT07822997 · Data updated 2026-11-12

This study tests a Brazilian Portuguese version of the EmPHasis-10 questionnaire to see if it reliably measures quality of life in adults with pulmonary hypertension in Porto Alegre, Brazil.

More Pulmonary Hypertension trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorHospital de Clinicas de Porto Alegre
Academic / other
Locations1 site (Porto Alegre)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedMarch 2027
Study endsJuly 2027
Registry record updatedSeptember 16, 2026
Trial IDNCT07822997 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with confirmed PAH (group 1) or CTEPH (group 4), native Brazilian Portuguese speakers, clinically stable for at least 3 months, and able to provide informed consent.

Probably not a fit

Patients not meeting language, diagnostic, or stability criteria may not benefit from this validation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a cross-sectional observational study to translate, culturally adapt, and validate the EmPHasis-10 quality-of-life questionnaire for Brazilian patients with precapillary pulmonary hypertension (PAH and CTEPH). The process includes forward translations, back-translation, expert review, pilot testing, and final adjustments guided by PHA-UK guidelines. Fifty adult patients will be recruited from the Pulmonary Circulation Outpatient Clinic at Hospital de Clínicas de Porto Alegre, with inclusion criteria focusing on native Brazilian Portuguese speakers who are clinically stable and on confirmed diagnoses. The study aims to establish the Brazilian Portuguese version's reliability, validity, and comprehension to support local risk stratification and patient-centered care.

Why it matters

Potential benefit: If successful, clinicians in Brazil will have a validated, easy-to-use QoL tool to help monitor and manage patients with pulmonary hypertension.

How similar studies have gone: Prior studies in other languages have shown EmPHasis-10 to correlate well with clinical outcomes across PH populations, supporting cross-cultural validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willingness to participate in the study after being informed and having provided written informed consent;
* Age ≥ 18 years;
* Diagnosis of precapillary pulmonary hypertension from groups 1 and 4, confirmed by right heart catheterization;
* Clinically stable patients with no changes in therapy for at least 3 months;
* Native speaker of Brazilian Portuguese;
* Literate patient.

Exclusion Criteria:

* Diagnosis of pulmonary hypertension from groups 2, 3, and/or 5;
* Spirometry showing forced vital capacity (FVC) ≤ 70% predicted and/or forced expiratory volume in the first second (FEV₁) ≤ 60% predicted;
* Severe communication impairment, including major cognitive deficit or severe hearing or visual impairment, resulting in inability to respond to the questionnaires or to understand the study procedures;
* Patients who experience clinical exacerbation or worsening between the days on which the questionnaires are administered;
* Refusal to participate in the study.

Where it's running

  • Hospital de Clínicas de Porto Alegre
    Porto Alegre, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.